What is Grifols S.A?
, together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 7.19B, and a P/E ratio of 15.3x.
A short list of Drug Manufacturers - General names that are close enough in size to make side-by-side comparison useful.